Catena Pharmaceuticals' Seed VC Round

Catena Pharmaceuticals raised a round of funding on October 20, 2008. Investors include Golden Pine Ventures.

Catena Pharmaceuticals is focused on the development and commercialization of GPCR antagonists, particularly in the areas of cancer and fibrotic disease. Catena's chemistry is capable of affecting a…

Articles about Catena Pharmaceuticals' Seed VC Round: